Press releases
February 28, 2022
Montagu as new investor
February 28, 2022
HTL announces that Montagu, a leading private equity firm, has acquired a majority stake of HTL previously held by Bridgepoint. The other minority shareholders, Naxicap and Téthys Invest, will keep their shares in the company.
The arrival of this new shareholder symbolizes the international success of a company that has become the world leader in the development and production of pharmaceutical grade biopolymers.
To see our most recent news,
Read more
news from us
-
Articles April 16, 2024HTL Biotechnology at In-cosmetics Global Congress in Paris
As every year, the In-Cosmetics Global Congress returns to Paris, with top industry leaders and experts gathering under one roof.
This event promises opportunities and insights into the future of Cosmetics. -
Articles April 9, 2024France BioLead Membership
France BioLead structures, pilots, supports and promotes the French biomanufacturing sector.
-
Articles March 28, 2024Attending AMWC in Monaco
AMWC, the Aesthetic & Anti-Aging Medicine World Congress in Monaco.